Bayesian Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$17.9M |
| 2 |
Target
TGT
|
+$7.23M |
| 3 |
Oracle
ORCL
|
+$5.76M |
| 4 |
Honeywell
HON
|
+$5.03M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$4.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$7.8M |
| 2 |
Alibaba
BABA
|
+$7.75M |
| 3 |
Micron Technology
MU
|
+$7.71M |
| 4 |
Procter & Gamble
PG
|
+$6.56M |
| 5 |
Netflix
NFLX
|
+$4.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.6% |
| 2 | Consumer Discretionary | 15.94% |
| 3 | Healthcare | 12.95% |
| 4 | Industrials | 11.61% |
| 5 | Consumer Staples | 10.69% |
Similar funds
Bayesian Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Bayesian Capital Management held 763 positions worth $484M, down 7.1% from $521M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Bayesian Capital Management withdrew a net $56.6M in Q2 2019, closing 279 positions and reducing 133 holdings. Its most notable exit was Accenture, an estimated $7.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Bayesian Capital Management opened a new position in Walgreens Boots Alliance worth $18.4M.
- Bayesian Capital Management's largest Q2 2019 buy was Walgreens Boots Alliance: 336,390 shares worth $18.4M.
- Bayesian Capital Management added most to Honeywell in Q2 2019, an estimated $5.03M increase.
- Bayesian Capital Management's biggest Q2 2019 reduction was Foot Locker, cutting an estimated $4.82M.
- Bayesian Capital Management fully exited Accenture in Q2 2019, selling an estimated $7.8M.
- Bayesian Capital Management's ten largest holdings make up 15% of its $484M portfolio in Q2 2019.
- Bayesian Capital Management opened 237 new positions and closed 279 in Q2 2019.
- Bayesian Capital Management's portfolio value fell 7.1% quarter-over-quarter to $484M.
Based on Bayesian Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.